Molecular Genetics and Metabolism Reports (Mar 2022)

Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study

  • Renzo Mignani,
  • Federico Pieruzzi

Journal volume & issue
Vol. 30
p. 100838

Abstract

Read online

No abstracts available.